Q32 Bio Inc.
Status: Publicly traded
Direct answer
Q32 Bio Inc. is publicly traded on NASDAQ under the ticker QTTB.
Operating as a clinical-stage biotechnology firm, Q32 Bio Inc. is dedicated to developing biologic therapies aimed at re-establishing healthy immune equilibrium in patients across the United States suffering from autoimmune and inflammatory disorders stemming from dysfunctional immune responses. The company's primary investigational therapy, ADX-097, is a humanized anti-C3d monoclonal antibody fusion protein...
Can you invest in Q32 Bio Inc.?
Yes. Q32 Bio Inc. is publicly traded on NASDAQ under the ticker QTTB.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Q32 Bio Inc.
Detailed equity research is provided by MarketSnap.